Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00003878 · ClinicalTrials.gov registry record · Phase 2
Carmustine Implants in Treating Patients With Brain Metastases
A Phase 2 study, sponsored by New Approaches to Brain Tumor Therapy Consortium.
- Completed
- Registry status
- Phase 2
- Development phase
NCT00003878: Completed Phase 2 study, sponsored by New Approaches to Brain Tumor Therapy Consortium.
NCT00003878 is a Phase 2 study that has completed, run by New Approaches to Brain Tumor Therapy Consortium. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00003878, a Phase 2 study, has completed, sponsored by New Approaches to Brain Tumor Therapy Consortium.
- COMPLETED
- Registry status
- Phase 2
- Development phase
Study Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Giving the drugs in different ways may kill more tumor cells. PURPOSE: Phase II trial to study the effectiveness of implanted carmustine wafers in treating patients who have brain metastases and who are undergoing surgery to remove the tumor.
Interventions
- PROCEDURE conventional surgery
- DRUG polifeprosan 20 with carmustine implant
Trial Details
| Field | Value |
|---|---|
| Start Date | 2002-04 |
| Est. Completion | 2003-04 |
| Phase | Phase 2 |
What the finished NCT00003878 record still lists
NCT00003878 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 0 conditions, and to 2 interventions - of which conventional surgery is the first listed.
NCT00003878 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00003878 about?
NCT00003878 is a clinical study titled "Carmustine Implants in Treating Patients With Brain Metastases". RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Giving the drugs in different ways may kill more tumor cells. PURPOSE: Phase II trial to study the effectiveness of implanted carmustine wafers in treating patients who have brain...
What is the current status of trial NCT00003878?
This trial is currently completed. It is a Phase 2 study. The study started on 2002-04. Estimated completion is 2003-04.
What interventions are being tested in trial NCT00003878?
The interventions under investigation include: conventional surgery (PROCEDURE), polifeprosan 20 with carmustine implant (DRUG).
Who is sponsoring clinical trial NCT00003878?
This trial is sponsored by New Approaches to Brain Tumor Therapy Consortium, which has 10 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia